Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe community-acquired Acinetobacter pneumonia].

Kouji Kanemoto1, Ryouko Ogawa, Kouichi Kurishima

  • 1Department of Respiratory Medicine, Tsukuba Medical Center Hospital.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|December 10, 2003
PubMed
Summary

Community-acquired Acinetobacter pneumonia is a rare but severe infection. This case highlights its rapid progression and high mortality, even with prompt medical care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysema.

Respiratory medicine·2025
Same author

Concomitant Interstitial Pneumonia and Disseminated BCG Infection after Intravesical BCG Therapy.

Internal medicine (Tokyo, Japan)·2024
Same author

Clinical and Microbiological Characteristics of Bacteremia Caused by Carbapenemase-producing Enterobacterales in Minami Ibaraki Area, Japan.

Journal of microorganism control·2024
Same author

Centrilobular emphysema and airway dysanapsis: factors associated with low respiratory function in younger smokers.

ERJ open research·2024
Same author

Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI).

Anticancer research·2023
Same author

Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI).

In vivo (Athens, Greece)·2023

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • A 62-year-old male with pre-existing conditions including atrial fibrillation, hypertension, and fatty liver presented with symptoms suggestive of pneumonia.
  • The patient was a heavy smoker with a history of regular alcohol consumption, increasing his risk factors for severe respiratory illness.

Observation:

  • Initial presentation included productive cough, fever, and dyspnea, with chest radiography revealing lobar pneumonia.
  • Despite antibiotic treatment, the patient's condition rapidly worsened, leading to transfer to a specialized hospital.

Findings:

  • On admission, the patient exhibited multi-lobar pneumonia, septic shock, and disseminated intravascular coagulation.
  • Blood and sputum cultures confirmed Acinetobacter species as the causative agent of pneumonia.

Related Experiment Videos

  • The patient succumbed to the illness within 9 hours of admission, despite aggressive medical interventions.

    • Implications:

    • Community-acquired Acinetobacter pneumonia, though rare in Japan, presents a fulminant clinical course and high mortality rate.
    • Physicians should maintain a high index of suspicion for Acinetobacter pneumonia in severe community-acquired pneumonia cases, particularly those with rapid deterioration.
    • Awareness of this pathogen is crucial for timely diagnosis and management to potentially improve patient outcomes.